You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-cardiac Troponin I (phospho T143) antibody (ab58546)

Overview

  • Product nameAnti-cardiac Troponin I (phospho T143) antibodySee all Cardiac Troponin I primary antibodies ...
  • Description
    Rabbit polyclonal to cardiac Troponin I (phospho T143)
  • SpecificityDetects endogenous levels of cardiac Troponin I only when phosphorylated at threonine 142.
  • Tested applicationsWB, ELISA more details
  • Species reactivity
    Reacts with: Mouse, Rat, Human, Pig
  • Immunogen

    Synthetic phosphopeptide (Human) from around the phosphorylation site of threonine 142 (RPTPLR)

  • Positive controlMouse heart extract.

Properties

Applications

Our Abpromise guarantee covers the use of ab58546 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Notes
WB WB: 1/500 - 1/1000. Detects a band of approximately 30 kDa (predicted molecular weight: 24 kDa).
ELISA ELISA: 1/10000.

Target

  • FunctionTroponin I is the inhibitory subunit of troponin, the thin filament regulatory complex which confers calcium-sensitivity to striated muscle actomyosin ATPase activity.
  • Involvement in diseaseDefects in TNNI3 are the cause of cardiomyopathy familial hypertrophic type 7 (CMH7) [MIM:613690]. Familial hypertrophic cardiomyopathy is a hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death.
    Defects in TNNI3 are the cause of cardiomyopathy familial restrictive type 1 (RCM1) [MIM:115210]. RCM1 is an heart muscle disorder characterized by impaired filling of the ventricles with reduced diastolic volume, in the presence of normal or near normal wall thickness and systolic function.
    Defects in TNNI3 are the cause of cardiomyopathy dilated type 2A (CMD2A) [MIM:611880]. Dilated cardiomyopathy is a disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death.
    Defects in TNNI3 are the cause of cardiomyopathy dilated type 1FF (CMD1FF) [MIM:613286]. Dilated cardiomyopathy is a disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death.
  • Sequence similaritiesBelongs to the troponin I family.
  • Target information above from: UniProt accession P19429 The UniProt Consortium
    The Universal Protein Resource (UniProt) in 2010
    Nucleic Acids Res. 38:D142-D148 (2010) .

    Information by UniProt
  • Database links
  • Alternative names
      cardiac muscle antibodyCardiac troponin I antibodyCardiomyopathy, familial hypertrophic, 7, included antibody
      CMD1FF antibodyCMD2A antibodyCMH7 antibodycTnI antibodyFamilial hypertrophic cardiomyopathy 7 antibodyMGC116817 antibodyRCM1 antibodyTn1 antibodyTni antibodyTNN I3 antibodyTNNC 1 antibodyTNNC1 antibodyTNNI3 antibodyTNNI3_HUMAN antibodyTroponin I antibodyTroponin I cardiac antibodyTroponin I cardiac muscle antibodyTroponin I cardiac muscle isoform antibodyTroponin I type 3 cardiac antibodytroponin I, cardiac 3 antibodyTroponinI antibodyTtroponin I type 3 (cardiac) antibody
    see all

Anti-cardiac Troponin I (phospho T143) antibody images

  • All lanes : Anti-cardiac Troponin I (phospho T143) antibody (ab58546) at 1/500 dilution

    Lane 1 : Mouse heart extract without immunizing peptide
    Lane 2 : Mouse heart extract with immunizing peptide


    Predicted band size : 24 kDa
    Observed band size : 30 kDa (why is the actual band size different from the predicted?)

References for Anti-cardiac Troponin I (phospho T143) antibody (ab58546)

This product has been referenced in:
  • Boontje NM  et al. Enhanced myofilament responsiveness upon ß-adrenergic stimulation in post-infarct remodeled myocardium. J Mol Cell Cardiol 50:487-99 (2011). WB ; Pig . Read more (PubMed: 21156182) »
  • Ladage D  et al. Inhibition of PKCa/ß with ruboxistaurin antagonizes heart failure in pigs after myocardial infarction injury. Circ Res 109:1396-400 (2011). WB ; Pig . Read more (PubMed: 21998327) »

See all 2 Publications for this product

Product Wall

Filter by Application

Filter by Species

Filter by Ratings

Application Western blot
Sample Rat Cell lysate - whole cell (ventricular myocytes)
Loading amount 40 µg
Specification ventricular myocytes
Treatment + or - ISO
Gel Running Conditions Reduced Denaturing (8-20% gradient SDS PAGE)
Blocking step BSA as blocking agent for 30 minute(s) · Concentration: 3% · Temperature: 22°C
Username

Verified customer

Submitted Jul 15 2008

Application Western blot
Sample Mouse Cell lysate - whole cell (Cardiac myocytes)
Loading amount 15000 cells
Specification Cardiac myocytes
Treatment 20uM phenylephrine 20 min 37C
Gel Running Conditions Reduced Denaturing (15%)
Blocking step BSA as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 5% · Temperature: 20°C
Username

Verified customer

Submitted Apr 25 2008

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"